MX2015000217A - Composiciones lipidicas de racecadotrilo. - Google Patents
Composiciones lipidicas de racecadotrilo.Info
- Publication number
- MX2015000217A MX2015000217A MX2015000217A MX2015000217A MX2015000217A MX 2015000217 A MX2015000217 A MX 2015000217A MX 2015000217 A MX2015000217 A MX 2015000217A MX 2015000217 A MX2015000217 A MX 2015000217A MX 2015000217 A MX2015000217 A MX 2015000217A
- Authority
- MX
- Mexico
- Prior art keywords
- lipid compositions
- racecadotril
- racecadotril lipid
- compositions
- lipid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Una composición lipídica que comprende racecadotrilo, al menos un surfactante y un lípido.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261665470P | 2012-06-28 | 2012-06-28 | |
US201361787597P | 2013-03-15 | 2013-03-15 | |
PCT/US2013/048593 WO2014005032A1 (en) | 2012-06-28 | 2013-06-28 | Racecadotril lipid compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2015000217A true MX2015000217A (es) | 2015-04-10 |
Family
ID=48790652
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015000217A MX2015000217A (es) | 2012-06-28 | 2013-06-28 | Composiciones lipidicas de racecadotrilo. |
Country Status (17)
Country | Link |
---|---|
US (1) | US10039712B2 (es) |
EP (1) | EP2866789B1 (es) |
JP (1) | JP6282645B2 (es) |
KR (1) | KR20150023876A (es) |
CN (1) | CN104411299B (es) |
AU (1) | AU2013282413B2 (es) |
BR (1) | BR112014032759A2 (es) |
CA (1) | CA2876929A1 (es) |
CO (1) | CO7160080A2 (es) |
HK (1) | HK1208178A1 (es) |
IN (1) | IN2014DN11003A (es) |
MX (1) | MX2015000217A (es) |
NZ (1) | NZ702934A (es) |
PH (1) | PH12014502858A1 (es) |
RU (1) | RU2632441C2 (es) |
SG (1) | SG11201408509PA (es) |
WO (1) | WO2014005032A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2866789B1 (en) | 2012-06-28 | 2018-08-01 | Johnson & Johnson Consumer Inc. | Racecadotril lipid compositions |
US9801819B2 (en) * | 2012-06-28 | 2017-10-31 | Johnson & Johnson Consumer Inc. | Racecadotril compositions |
MA40859A (fr) * | 2014-10-29 | 2017-09-05 | Johnson & Johnson Consumer Inc | Particules de cadotril |
CN107921017A (zh) * | 2015-08-07 | 2018-04-17 | 强生消费者公司 | 使用卡多曲组合物进行治疗的方法 |
CN105125477A (zh) * | 2015-08-19 | 2015-12-09 | 黑龙江佰彤儿童药物研究有限公司 | 一种含消旋卡多曲的药物制剂及制备方法 |
BR112018013828A2 (pt) * | 2016-01-13 | 2018-12-11 | Johnson & Johnson Consumer Inc. | composição aprimorada que compreende ao menos uma cadotrila |
MA46051A (fr) * | 2016-08-23 | 2021-03-31 | Johnson & Johnson Consumer Inc | Nouvelle composition améliorée de racecadotril |
AU2019225236A1 (en) * | 2018-02-26 | 2020-09-10 | R.P. Scherer Technologies, Llc | Pharmaceutical dosage form for an emulsion of simethicone and loperamide |
CN117660024A (zh) * | 2019-07-08 | 2024-03-08 | 株式会社Moresco | 微型乳剂、用于制造微型乳剂的方法以及微型乳剂的用途 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2480747A1 (fr) | 1980-04-17 | 1981-10-23 | Roques Bernard | Derives d'acides amines et leur application therapeutique |
FR2623498B1 (fr) | 1987-11-24 | 1990-04-06 | Bioprojet Soc Civ | Nouveaux composes enantiomeres derives d'amino-acides, leur procede de preparation et leurs applications therapeutiques |
US5136076A (en) | 1987-11-24 | 1992-08-04 | Societe Civile Bioprojet | Process for the preparation of amino acid-derived enatiomeric compounds |
FR2673105B1 (fr) * | 1991-02-26 | 1995-01-13 | Bioprojet Soc Civ | Nouvelles compositions pharmaceutiques, notamment pour le traitement des colopathies fonctionnelles, et procedes de preparation de compositions et de medicaments, notamment pour le traitement de ces affections. |
SE9503143D0 (sv) * | 1995-09-12 | 1995-09-12 | Astra Ab | New preparation |
US20020028248A1 (en) | 1996-03-14 | 2002-03-07 | Takayuki Tsukada | Rapid-release microdispersible ecadotril preparation |
WO1998040051A1 (en) | 1997-03-12 | 1998-09-17 | Abbott Laboratories | Lipophilic binary systems for the administration of lipophilic compounds |
GB9907715D0 (en) | 1999-04-01 | 1999-05-26 | Scherer Corp R P | Pharmaceutical compositions |
CA2415957C (en) | 2000-06-23 | 2010-08-10 | Bioprojet | Dry powder formulation comprising racecadotril |
GB0015490D0 (en) | 2000-06-23 | 2000-08-16 | Smithkline Beecham Lab | Novel formulations |
EP1563848A1 (en) | 2004-02-12 | 2005-08-17 | Bioprojet | New combinations of an anti-emetic agent and an enkephalinase inhibitor |
FR2900823B1 (fr) * | 2006-05-15 | 2009-02-13 | Bioprojet Soc Civ Ile | Nouvelle forme d'administration du racecadotril. |
CN101103960B (zh) | 2006-07-14 | 2010-12-08 | 海南盛科生命科学研究院 | 一种含有消旋卡多曲的干混悬剂及其制备方法 |
CN101264065A (zh) * | 2008-04-18 | 2008-09-17 | 盐城苏海制药有限公司 | 消旋卡多曲滴丸及其制备方法 |
US20100330169A1 (en) | 2009-06-29 | 2010-12-30 | Frank Bunick | Pharmaceutical Tablet Containing A Liquid Filled Capsule |
CN102018707A (zh) | 2010-11-29 | 2011-04-20 | 昆明邦宇制药有限公司 | 一种治疗腹泻的药物组合物及其制剂 |
EP2462922A1 (en) * | 2010-12-10 | 2012-06-13 | Bioprojet | New form of administration of enkephalinase inhibitor |
CN102133186B (zh) * | 2011-03-18 | 2012-08-01 | 海南美大制药有限公司 | 一种消旋卡多曲脂质体固体制剂 |
CN102327234B (zh) | 2011-09-28 | 2017-04-12 | 海南康芝药业股份有限公司 | 一种消旋卡多曲干混悬剂 |
BR112014032801A2 (pt) | 2012-06-28 | 2017-06-27 | Mcneil Ppc Inc | composições líquidas de racecadotril |
US9801819B2 (en) | 2012-06-28 | 2017-10-31 | Johnson & Johnson Consumer Inc. | Racecadotril compositions |
US9114171B2 (en) | 2012-06-28 | 2015-08-25 | Mcneil-Ppc, Inc. | Racecadotril liquid compositions |
EP2866789B1 (en) | 2012-06-28 | 2018-08-01 | Johnson & Johnson Consumer Inc. | Racecadotril lipid compositions |
TR201801726T4 (tr) | 2012-12-26 | 2018-03-21 | Ilko Ilac Sanayi Veticaret A S | Rasekadotri̇l ve farmasöti̇k bi̇leşi̇mleri̇. |
CN107921017A (zh) | 2015-08-07 | 2018-04-17 | 强生消费者公司 | 使用卡多曲组合物进行治疗的方法 |
-
2013
- 2013-06-28 EP EP13737087.0A patent/EP2866789B1/en active Active
- 2013-06-28 RU RU2015102597A patent/RU2632441C2/ru active
- 2013-06-28 JP JP2015520576A patent/JP6282645B2/ja not_active Expired - Fee Related
- 2013-06-28 KR KR20157001954A patent/KR20150023876A/ko not_active Application Discontinuation
- 2013-06-28 BR BR112014032759A patent/BR112014032759A2/pt not_active Application Discontinuation
- 2013-06-28 CA CA2876929A patent/CA2876929A1/en not_active Abandoned
- 2013-06-28 WO PCT/US2013/048593 patent/WO2014005032A1/en active Application Filing
- 2013-06-28 CN CN201380034826.3A patent/CN104411299B/zh not_active Expired - Fee Related
- 2013-06-28 US US13/929,996 patent/US10039712B2/en active Active
- 2013-06-28 MX MX2015000217A patent/MX2015000217A/es unknown
- 2013-06-28 AU AU2013282413A patent/AU2013282413B2/en not_active Ceased
- 2013-06-28 NZ NZ702934A patent/NZ702934A/en not_active IP Right Cessation
- 2013-06-28 SG SG11201408509PA patent/SG11201408509PA/en unknown
-
2014
- 2014-12-19 CO CO14279647A patent/CO7160080A2/es unknown
- 2014-12-22 PH PH12014502858A patent/PH12014502858A1/en unknown
- 2014-12-23 IN IN11003DEN2014 patent/IN2014DN11003A/en unknown
-
2015
- 2015-09-10 HK HK15108866.7A patent/HK1208178A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CO7160080A2 (es) | 2015-01-15 |
SG11201408509PA (en) | 2015-01-29 |
AU2013282413B2 (en) | 2018-04-19 |
CA2876929A1 (en) | 2014-01-03 |
PH12014502858A1 (en) | 2015-02-23 |
JP2015522031A (ja) | 2015-08-03 |
US20140005262A1 (en) | 2014-01-02 |
CN104411299A (zh) | 2015-03-11 |
RU2015102597A (ru) | 2016-08-20 |
NZ702934A (en) | 2017-02-24 |
JP6282645B2 (ja) | 2018-02-21 |
BR112014032759A2 (pt) | 2017-06-27 |
US10039712B2 (en) | 2018-08-07 |
EP2866789A1 (en) | 2015-05-06 |
AU2013282413A1 (en) | 2015-01-22 |
RU2632441C2 (ru) | 2017-10-04 |
EP2866789B1 (en) | 2018-08-01 |
KR20150023876A (ko) | 2015-03-05 |
IN2014DN11003A (es) | 2015-09-25 |
WO2014005032A1 (en) | 2014-01-03 |
HK1208178A1 (en) | 2016-02-26 |
CN104411299B (zh) | 2017-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12014502858A1 (en) | Racecadotril lipid compositions | |
PH12015502014A1 (en) | Racecadotril lipid compositions | |
MX2012015188A (es) | Composiciones de liberacion controlada con efecto de alimentos reducido. | |
MY169141A (en) | Biodegradable compositions, methods and uses thereof | |
PH12014502860A1 (en) | Racecadotril liquid compositions | |
PH12015500900A1 (en) | A stabilized pemetrexed formulation | |
DK3027701T3 (en) | Compositions comprising 1,1-difluoroethene (r-1132a) | |
PL2666848T3 (pl) | Rozcieńczalna kompozycja środka powierzchniowo czynnego | |
AU337887S (en) | Allsaw | |
ZA201401782B (en) | Chromobacterium formulations,compositions,metabolites and their uses | |
IN2014MN02276A (es) | ||
AU2013225816A8 (en) | Compositions and methods for treating Type III Gaucher Disease | |
GEP201706739B (en) | Compositions comprising vortioxetine and donepezil | |
IL233824A (en) | Compounds 1h - Indazole - 3 - Carboxamide, preparations containing them and their use | |
PH12015502061A1 (en) | Racecadotril liquid compositions | |
MY165088A (en) | Pharmaceutical compositions comprising alisporivir | |
IL280316B (en) | Amphiphilic compounds, preparations and their use | |
IL237542B (en) | Amphiphilic compounds, their preparations and uses | |
MX2015008120A (es) | Composicion lubricante a base de eter de poliglicerol. | |
IL237540B (en) | Amphiphilic compounds, their preparations and uses | |
IL237538B (en) | Amphiphilic compounds, their preparations and uses | |
IL237539A0 (en) | Amphiphilic compounds, their preparations and uses | |
TN2013000218A1 (en) | Pharmaceutical compositions comprising alisporivir | |
UA54957U (ru) | Водорастворимые соли 3-бензилксантинил-8-метилтиоацетатной кислоты, которые проявляют антиоксидантное действие | |
AU340267S (en) | Kick scooters - stunt peg |